Publicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biobizkaia (14)

2024

  1. Recovery course of persistent posterior subretinal fluid after successful repair of rhegmatogenous retinal detachment

    European Journal of Ophthalmology, Vol. 34, Núm. 4, pp. 1217-1227

2022

  1. Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry

    Seminars in Arthritis and Rheumatism, Vol. 55

  2. Transcriptomic analysis of patients with clinical suspicion of maturity-onset diabetes of the young (MODY) with a negative genetic diagnosis

    Orphanet journal of rare diseases, Vol. 17, Núm. 1, pp. 105

2021

  1. Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507] (Autoimmunity Reviews (2020) 19(5), (S1568997220300598), (10.1016/j.autrev.2020.102507))

    Autoimmunity Reviews

  2. Effectiveness of two procedures for deploying a facilitated collaborative modeling implementation strategy—the PVS-PREDIAPS strategy—to optimize type 2 diabetes prevention in primary care: the PREDIAPS cluster randomized hybrid type II implementation trial

    Implementation Science, Vol. 16, Núm. 1

  3. Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study

    Medicina Intensiva, Vol. 45, Núm. 6, pp. 332-346

  4. Inpatient Hyperglycemia Management and COVID-19

    Diabetes Therapy, Vol. 12, Núm. 1, pp. 121-132

2020

  1. A Multinational Real-World Study on the Clinical Characteristics of Patients with Type 2 Diabetes Initiating Dapagliflozin in Southern Europe

    DIABETES THERAPY, Vol. 11, Núm. 2, pp. 423-436

  2. Consequences of COVID-19 on people with diabetes

    Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 6, pp. 355-356

  3. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease

    United European Gastroenterology Journal, Vol. 8, Núm. 9, pp. 1056-1066

  4. Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes

    Diabetes Research and Clinical Practice, Vol. 166

  5. Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation

    Autoimmunity Reviews, Vol. 19, Núm. 5

2018

  1. Bone metastasis located on foot as a clinical presentation of an adrenocortical carcinoma

    Endocrinologia, Diabetes y Nutricion, Vol. 65, Núm. 7, pp. 418-419

2016

  1. A Novel Mutation in a Patient with Hyperparathyroidism–Jaw Tumour Syndrome

    Endocrine Pathology, Vol. 27, Núm. 2, pp. 142-146